Strasbourg (FR) / Munich (DE) - July 9, 2020 - 8:30 am CET -Transgene and Hypertrust Patient Data Care today announced as a world premiere the first productive blockchain solution for clinical trials of personalized healthcare, leveraging the Hypertrust X-Chain for Clinical Trials product. The cloud-based solution monitors and orchestrates the supply chain processes of Transgene's AI-enhanced TG4050 individualized therapeutic vaccine based on the myvac® technology, against ovarian, head and neck cancer providing an immutable audit trail throughout the treatment process.
The innovative collaboration between Transgene and Hypertrust marks a milestone in the ongoing fight against cancer. The blockchain-based Hypertrust X-Chain solution supports Transgene's personalized immunotherapies comprehensively, ensuring a trustworthy process in the background of the medical treatment. All emerging personalized treatments have a massive need for trustworthy and decentralized solutions, due to the strong cross-company collaborative nature of the production process.
.../...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer